These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25672356)

  • 21. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants.
    Yang J; Luo Y; Li J; Ma Y; Hu C; Jin S; Ye L; Cui S
    J Antimicrob Chemother; 2010 Mar; 65(3):453-9. PubMed ID: 20056688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms.
    Rodríguez-Martínez JM; Santiso R; Machuca J; Bou G; Pascual Á; Fernández JL
    Microb Drug Resist; 2016 Jul; 22(5):354-9. PubMed ID: 26890225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008.
    Zhou TL; Chen XJ; Zhou MM; Zhao YJ; Luo XH; Bao QY
    Jpn J Infect Dis; 2011; 64(1):55-7. PubMed ID: 21266756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class 1 integrons in ciprofloxacin-resistant Escherichia coli strains from two Dutch hospitals.
    Mooij MJ; Schouten I; Vos G; Van Belkum A; Vandenbroucke-Grauls CM; Savelkoul PH; Schultsz C
    Clin Microbiol Infect; 2005 Nov; 11(11):898-902. PubMed ID: 16216105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum beta-lactamase-producing Escherichia coli in Madrid, Spain.
    Ríos E; Rodríguez-Avial I; Rodríguez-Avial C; Hernandez E; Picazo JJ
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):380-3. PubMed ID: 20638608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
    Oktem IM; Gulay Z; Bicmen M; Gur D;
    Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterisation of quinolone resistance in Escherichia coli from animals in Turkey.
    Cengiz M; Buyukcangaz E; Arslan E; Mat B; Sahinturk P; Sonal S; Gocmen H; Sen A
    Vet Rec; 2012 Aug; 171(6):155, 1-4. PubMed ID: 22890400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK.
    Corkill JE; Anson JJ; Hart CA
    J Antimicrob Chemother; 2005 Dec; 56(6):1115-7. PubMed ID: 16260446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
    Guillard T; Cambau E; Chau F; Massias L; de Champs C; Fantin B
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5830-5. PubMed ID: 24018262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
    Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of plasmid-mediated quinolone resistance in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].
    Coban AY; Tanrıverdi Çaycı Y; Yıldırım T; Erturan Z; Durupınar B; Bozdoğan B
    Mikrobiyol Bul; 2011 Oct; 45(4):602-8. PubMed ID: 22090290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Investigation of plasmid-mediated quinolone resistance in Escherichia coli strains].
    Aktepe OC; Aşık G; Cetinkol Y; Biçmen M; Gülay Z
    Mikrobiyol Bul; 2012 Jan; 46(1):9-16. PubMed ID: 22399166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H; Duan G; Zhu J; Zhang W; Xi Y; Fan Q
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV.
    Tran JH; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3050-2. PubMed ID: 15980397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
    Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD
    J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.